Hims & Hers Health (HIMS) is testing a far weaker technical setup after another sharp decline pushed the stock deeper into the lower end of its multiyear rally range.
HIMS traded near $25 a share as of Tuesday market close, falling below Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities
Subscribe to Newsletters To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser